NCT05381168

Brief Summary

The aims of this study are to explore efficacy and safety of calcium from fish bone in volunteers with osteopenia. The volunteers are divided into 2 groups which are calcium from fish bone treatment group and calcium carbonate treatment group. Both groups received the calciums everyday for 6 months. Bone mineral density, blood examination, physical examination, adverse events, and satisfaction are evaluated before and after treatment.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 5, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 19, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

May 20, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

May 19, 2022

Status Verified

May 1, 2022

Enrollment Period

6 months

First QC Date

May 5, 2022

Last Update Submit

May 18, 2022

Conditions

Keywords

osteopeniacalciumfish boneefficacysafety

Outcome Measures

Primary Outcomes (1)

  • Bone mineral density score

    Bone mineral density score is measured using dual energy x-ray absorptiometry scanner (DEXA scanner). It shows in term of T-score. The outcomes are compared bone mineral density score of calcium from fish bone group to calcium carbonate group.

    6 months

Secondary Outcomes (17)

  • Osteocalcin level

    6 months

  • Total procollagen type-1 N-terminal propeptide (P1NP) level

    6 months

  • Beta-crosslaps level

    6 months

  • Parathyroid hormone (PTH) level

    6 months

  • Blood calcium level

    6 months

  • +12 more secondary outcomes

Study Arms (2)

Calcium from fish bone

EXPERIMENTAL

The volunteer will receive calcium from fish bone 4 capsules per day for 6 months.

Dietary Supplement: Calcium from fish bone

Calcium carbonate

ACTIVE COMPARATOR

The volunteer will receive calcium carbonate 2 tablets per day for 6 months.

Dietary Supplement: Calcium carbonate

Interventions

Calcium from fish boneDIETARY_SUPPLEMENT

Calcium from fish bone contained calcium 312 mg and vitamin D 100 IU per capsule.

Calcium from fish bone
Calcium carbonateDIETARY_SUPPLEMENT

Calcium carbonate contained calcium 600 mg and vitamin D 200 IU per capsule.

Calcium carbonate

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Male age more than 70 years or female age more than 65 years or all age volunteers that have at least 1 risk factors which are menopause before 45 years, menopause with the height reduction (more than 4 cm), body mass index less than 20 kg/mm2, bone fracture history, taking some medicine that has an effect on bone density reduction, have disease that has an effect on bone density reduction, Father and mother have bone fracture history, fracture risk assessment tool (FRAX) in intermediate risk, osteoporosis self-assessment tool for asian (OSTA) score, khon kaen osteoporosis study (KKOS) score in intermediate risk or higher intermediate risk
  • Bone mineral density between -1 to -2.5
  • No osteosclerosis
  • Can read and write
  • Willing to be volunteer

You may not qualify if:

  • Allergic to calcium, magnesium, phosphorus, zinc, collagen, and osteocalcin
  • Taking calcium or vitamin D with in 14 days before the study start
  • Taking osteosclerosis' medicine
  • Have uncontrolled diseases
  • Pregnancy and lactation
  • Participating in other study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Bone Diseases, Metabolic

Interventions

Calcium Carbonate

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Calcium CompoundsInorganic ChemicalsCarbonatesCarbonic AcidCarbon Compounds, InorganicMinerals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The volunteers are divided into 2 groups which are calcium from fish bone treatment group and calcium carbonate treatment group. Both groups receive the calciums every day for 6 months.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 5, 2022

First Posted

May 19, 2022

Study Start

May 20, 2022

Primary Completion

November 30, 2022

Study Completion

December 31, 2022

Last Updated

May 19, 2022

Record last verified: 2022-05